Efficacy and safety of extended-release fluvastatin in Turkish patients with hypercholesterolaemia: TULIPS (Turkish Lipid Study)


Ilerigelen B., Ueresin Y., San M., Kueltuesay H., Gueneri S., Serdar O. A., ...More

CURRENT MEDICAL RESEARCH AND OPINION, vol.23, no.5, pp.1093-1102, 2007 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 23 Issue: 5
  • Publication Date: 2007
  • Doi Number: 10.1185/030079907x187847
  • Journal Name: CURRENT MEDICAL RESEARCH AND OPINION
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1093-1102
  • Keywords: extended-release, fluvastatin, hypercholesterolaemia, low-density lipoprotein cholesterol, triglycerides, C-REACTIVE PROTEIN, CORONARY-ARTERY-DISEASE, CHOLESTEROL LEVELS, STATIN THERAPY, CARDIAC EVENTS, RISK, PREVENTION, MORTALITY, PHARMACOKINETICS, ATHEROSCLEROSIS
  • Dokuz Eylül University Affiliated: No

Abstract

Objective:The efficacy and safety of extended-release fluvastatin (fluvastatin XL), 80 mg once daily, was assessed in Turkish patients with primary hypercholesterolaemia (low-density lipoprotein cholesterol (LDL-C) 3.37-5.70 mmol/l and triglyceride (TG) < 4.52 mmol/l).